Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase-dependent metabolic pathways
- PMID: 15545402
- PMCID: PMC2234027
- DOI: 10.1085/jgp.200409140
Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase-dependent metabolic pathways
Abstract
We used the patch-clamp technique to study the effect of arachidonic acid (AA) on epithelial Na channels (ENaC) in the rat cortical collecting duct (CCD). Application of 10 microM AA decreased the ENaC activity defined by NPo from 1.0 to 0.1. The dose-response curve of the AA effect on ENaC shows that 2 microM AA inhibited the ENaC activity by 50%. The effect of AA on ENaC is specific because neither 5,8,11,14-eicosatetraynoic acid (ETYA), a nonmetabolized analogue of AA, nor 11,14,17-eicosatrienoic acid mimicked the inhibitory effect of AA on ENaC. Moreover, inhibition of either cyclooxygenase (COX) with indomethacin or cytochrome P450 (CYP) omega-hydroxylation with N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS) failed to abolish the effect of AA on ENaC. In contrast, the inhibitory effect of AA on ENaC was absent in the presence of N-methylsulfonyl-6-(propargyloxyphenyl)hexanamide (MS-PPOH), an agent that inhibits CYP-epoxygenase activity. The notion that the inhibitory effect of AA is mediated by CYP-epoxygenase-dependent metabolites is also supported by the observation that application of 200 nM 11,12-epoxyeicosatrienoic acid (EET) inhibited ENaC in the CCD. In contrast, addition of 5,6-, 8,9-, or 14,15-EET failed to decrease ENaC activity. Also, application of 11,12-EET can still reduce ENaC activity in the presence of MS-PPOH, suggesting that 11,12-EET is a mediator for the AA-induced inhibition of ENaC. Furthermore, gas chromatography mass spectrometry analysis detected the presence of 11,12-EET in the CCD and CYP2C23 is expressed in the principal cells of the CCD. We conclude that AA inhibits ENaC activity in the CCD and that the effect of AA is mediated by a CYP-epoxygenase-dependent metabolite, 11,12-EET.
Figures
![F<sc>igure</sc> 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2234027/bin/200409140f1.gif)
![F<sc>igure</sc> 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2234027/bin/200409140f2.gif)
![F<sc>igure</sc> 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2234027/bin/200409140f3.gif)
![F<sc>igure</sc> 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2234027/bin/200409140f4.gif)
![F<sc>igure</sc> 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2234027/bin/200409140f5.gif)
![F<sc>igure</sc> 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2234027/bin/200409140f6.gif)
![F<sc>igure</sc> 7.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2234027/bin/200409140f7.gif)
![F<sc>igure</sc> 8.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2234027/bin/200409140f8.gif)
![F<sc>igure</sc> 9.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2234027/bin/200409140f9.gif)
![F<sc>igure</sc> 10.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2234027/bin/200409140f10.gif)
![F<sc>igure</sc> 11.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2234027/bin/200409140f11.gif)
![F<sc>igure</sc> 12.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2234027/bin/200409140f12.gif)
![F<sc>igure</sc> 13.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2234027/bin/200409140f13.gif)
Similar articles
-
Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.Drug Metab Rev. 2014 Feb;46(1):33-56. doi: 10.3109/03602532.2013.837916. Epub 2013 Sep 16. Drug Metab Rev. 2014. PMID: 24040964 Review.
-
Role of cytochrome P450 epoxygenase in regulating renal membrane transport and hypertension.Curr Opin Nephrol Hypertens. 2013 Mar;22(2):163-9. doi: 10.1097/MNH.0b013e32835d911e. Curr Opin Nephrol Hypertens. 2013. PMID: 23302865 Free PMC article. Review.
-
Arachidonic acid inhibits basolateral K channels in the cortical collecting duct via cytochrome P-450 epoxygenase-dependent metabolic pathways.Am J Physiol Renal Physiol. 2008 Jun;294(6):F1441-7. doi: 10.1152/ajprenal.00038.2008. Epub 2008 Apr 16. Am J Physiol Renal Physiol. 2008. PMID: 18417544 Free PMC article.
-
Low Na intake suppresses expression of CYP2C23 and arachidonic acid-induced inhibition of ENaC.Am J Physiol Renal Physiol. 2006 Dec;291(6):F1192-200. doi: 10.1152/ajprenal.00112.2006. Epub 2006 Jul 18. Am J Physiol Renal Physiol. 2006. PMID: 16849695
-
Adenosine inhibits ENaC via cytochrome P-450 epoxygenase-dependent metabolites of arachidonic acid.Am J Physiol Renal Physiol. 2006 May;290(5):F1163-8. doi: 10.1152/ajprenal.00301.2005. Epub 2005 Oct 18. Am J Physiol Renal Physiol. 2006. PMID: 16234312
Cited by
-
The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids.Front Pharmacol. 2024 Apr 2;15:1358256. doi: 10.3389/fphar.2024.1358256. eCollection 2024. Front Pharmacol. 2024. PMID: 38628644 Free PMC article. Review.
-
Fibrinolytic system and COVID-19: From an innovative view of epithelial ion transport.Biomed Pharmacother. 2023 Jul;163:114863. doi: 10.1016/j.biopha.2023.114863. Epub 2023 May 9. Biomed Pharmacother. 2023. PMID: 37172333 Free PMC article. Review.
-
Hypertension and human immunodeficiency virus: A paradigm for epithelial sodium channels?Front Cardiovasc Med. 2022 Aug 25;9:968184. doi: 10.3389/fcvm.2022.968184. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36093171 Free PMC article. Review.
-
Perspectives on Potential Fatty Acid Modulations of Motility Associated Human Sperm Ion Channels.Int J Mol Sci. 2022 Mar 28;23(7):3718. doi: 10.3390/ijms23073718. Int J Mol Sci. 2022. PMID: 35409078 Free PMC article. Review.
-
Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney.J Biol Chem. 2021 Jan-Jun;296:100667. doi: 10.1016/j.jbc.2021.100667. Epub 2021 Apr 16. J Biol Chem. 2021. PMID: 33864813 Free PMC article.
References
-
- Buckley, B.J., and A.R. Whorton. 1995. Arachidonic acid stimulates protein tyrosine phosphorylation in vascular cells. Am. J. Physiol. 269:C1489–C1495. - PubMed
-
- Carattino, M.D., W.G. Hill, and T.R. Kleyman. 2003. Arachidonic acid regulates surface expression of epithelial sodium channels. J. Biol. Chem. 278:36202–36213. - PubMed
-
- Chen, J.K., J.H. Capdevila, D.C. Zeldin, and R.L. Rosenberg. 1999. a. Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids. Mol. Pharmacol. 55:288–295. - PubMed
-
- Chen, J.K., D.W. Wang, J.R. Falck, J.H. Capdevila, and R.C. Harris. 1999. b. Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor. J. Biol. Chem. 274:4764–4769. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources